%0 Journal Article
%T X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world
%A Ahmed Aziz Bousfiha
%A Alessandro Plebani
%A Alla Volokha
%A Ana Maria Vinet
%A Anna Sediva
%A Anna Shcherbina
%A Antonio Condino-Neto
%A Aydan Ikinciogullari
%A Beata Derfalvi
%A Berta Sanchez
%A Brian Eley
%A Caterina Cancrini
%A Claudio Pignata
%A Ebtihal Kamal
%A Edith Gonzalez Serrano
%A Elham Hossny
%A Farah Naz Qamar
%A Figen Dogu
%A Filomeen Haerynck
%A Ghassan Dbaibo
%A Guiseppe Spadaro
%A Hirokazu Kanegane
%A Irina Abramova
%A J.David M. Edgar
%A Joao Farela Neves
%A John Routes
%A Juan Carlos Aldave
%A Kathleen E. Sullivan
%A Kenneth Paris
%A Liliana Bezrodnik
%A Mikko RJ. Seppanen
%A Mimi Tang
%A Monia Ouederni
%A Nadia Kechout
%A Nelson Rosario
%A Nermeen Galal
%A Nima Rezaei
%A Nita Radhakrishnan
%A Rachida Boukari
%A Rasha Hasan El-Owaidy
%A Rima Hanna-Wakim
%A Roberto Paganelli
%A Sangeetha Siniah
%A Sara Elva Espinosa-Padilla
%A Sonia Qureshi
%A Surjit Singh
%A Tomohiro Morio
%A Viviana Moschese
%A Waleed Al-Herz
%A Yu Lung Lau
%A Zeinab A. El-Sayed
%J Archive of "The World Allergy Organization Journal".
%D 2019
%R 10.1016/j.waojou.2019.100018
%X X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features
%K XLA
%K Agammaglobulinemia
%K Infection
%K Autoimmunity
%K Outcomes
%K Immunoglobulin
%K Therapy CLD
%K Chronic lung disease
%K FH
%K Family history
%K GI
%K Gastrointestinal
%K JIA
%K juvenile idiopathic arthritis
%K SCIG
%K Subcutaneous immunoglobulin
%K VAPP
%K Vaccine associated paralytic poliomyelitis
%K XLA
%K X-linked agammaglobulinemia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439403/